Novo Nordisk (NVO.US) has filed a preliminary injunction motion in the U.S. District Court for New Jersey, seeking an immediate halt to Eli Lilly's (LLY.US) misleading GLP-1 advertising campaign during the course of its lawsuit.

Novo Nordisk (NVO.US) has filed a preliminary injunction motion in the U.S. District Court for New Jersey, seeking an immediate halt to Eli Lilly's (LLY.US) misleading GLP-1 advertising campaign during the course of its lawsuit.

智通财经2026/07/24 08:42

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Novo Nordisk (NVO.US): Filed a motion for a preliminary injunction in the U.S. District Court for the New Jersey area, requesting an immediate halt to Eli Lilly's (LLY.US) misleading GLP-1 advertising activities during the course of its litigation.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Novo Nordisk (NVO.US) has filed a preliminary injunction motion in the U.S. District Court for New Jersey, seeking an immediate halt to Eli Lilly's (LLY.US) misleading GLP-1 advertising campaign during the course of its lawsuit.

You may also like

Crypto prices